Molecularly, SCLC is defined by the near-universal inactivation of TP53 and RB1 and by the deregulation of neuroendocrine transcription factors such as ASCL1, NEUROD1, POU2F3, and YAP1 [2]. The gene discussed is POU2F3; the disease is small cell lung carcinoma.